These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

830 related items for PubMed ID: 19157507

  • 21. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B.
    Cancer; 2007 Jan 15; 109(2):228-38. PubMed ID: 17167759
    [Abstract] [Full Text] [Related]

  • 22. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
    Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B.
    Hum Pathol; 2009 Oct 15; 40(10):1453-60. PubMed ID: 19454358
    [Abstract] [Full Text] [Related]

  • 23. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V.
    J Pathol; 2000 Dec 15; 192(4):460-9. PubMed ID: 11113863
    [Abstract] [Full Text] [Related]

  • 24. Enhanced peroxisome proliferator-activated receptor-gamma expression in monocyte/macrophages from coronary artery disease patients and possible gender differences.
    Amoruso A, Bardelli C, Fresu LG, Palma A, Vidali M, Ferrero V, Ribichini F, Vassanelli C, Brunelleschi S.
    J Pharmacol Exp Ther; 2009 Nov 15; 331(2):531-8. PubMed ID: 19644041
    [Abstract] [Full Text] [Related]

  • 25. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B.
    Hum Pathol; 2012 May 15; 43(5):669-74. PubMed ID: 21855113
    [Abstract] [Full Text] [Related]

  • 26. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
    Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM.
    Hum Pathol; 2011 Jul 15; 42(7):991-7. PubMed ID: 21315424
    [Abstract] [Full Text] [Related]

  • 27. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
    Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F.
    Am J Clin Pathol; 2005 Mar 15; 123(3):360-8. PubMed ID: 15716231
    [Abstract] [Full Text] [Related]

  • 28. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis.
    Kang HJ, Cinn YG, Hwang SJ, Won Chae S, Woo JS, Lee SH, Lee HM.
    Arch Otolaryngol Head Neck Surg; 2006 Nov 15; 132(11):1196-200. PubMed ID: 17116814
    [Abstract] [Full Text] [Related]

  • 29. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
    Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM.
    Gynecol Oncol; 2005 Jan 15; 96(1):42-7. PubMed ID: 15589578
    [Abstract] [Full Text] [Related]

  • 30. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M.
    Gynecol Oncol; 2000 Apr 15; 77(1):35-43. PubMed ID: 10739688
    [Abstract] [Full Text] [Related]

  • 31. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
    Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA.
    Cancer; 2007 Sep 15; 110(6):1264-71. PubMed ID: 17647260
    [Abstract] [Full Text] [Related]

  • 32. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
    Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA.
    Clin Cancer Res; 2003 Jun 15; 9(6):2248-59. PubMed ID: 12796393
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A, Pazienza V, Pugnale P, Bruttin F, Rubbia-Brandt L, Juge-Aubry CE, Meier CA, Hadengue A, Negro F.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):107-14. PubMed ID: 16393287
    [Abstract] [Full Text] [Related]

  • 34. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
    Elstrand MB, Stavnes HT, Tropé CG, Davidson B.
    Hum Pathol; 2012 Apr 01; 43(4):529-35. PubMed ID: 21864883
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities.
    Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B.
    Diagn Cytopathol; 2005 Nov 01; 33(5):332-7. PubMed ID: 16240397
    [Abstract] [Full Text] [Related]

  • 36. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B, Dong HP, Holth A, Berner A, Risberg B.
    Breast J; 2008 Nov 01; 14(5):476-82. PubMed ID: 18657145
    [Abstract] [Full Text] [Related]

  • 37. Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis.
    Sueyoshi S, Mitsumata M, Kusumi Y, Niihashi M, Esumi M, Yamada T, Sakurai I.
    Pathol Res Pract; 2010 Jul 15; 206(7):429-38. PubMed ID: 20399568
    [Abstract] [Full Text] [Related]

  • 38. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
    Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B.
    Gynecol Oncol; 2013 May 15; 129(2):358-63. PubMed ID: 23438671
    [Abstract] [Full Text] [Related]

  • 39. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
    Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R.
    Gynecol Oncol; 2006 Sep 15; 102(3):453-61. PubMed ID: 16494928
    [Abstract] [Full Text] [Related]

  • 40. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
    Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J.
    Clin Cancer Res; 2001 Dec 15; 7(12):4073-9. PubMed ID: 11751504
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.